Offerings // GYRE THERAPEUTICS, INC.

GYRE offering history

Every offering-related filing in GYRE THERAPEUTICS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Oct 1, 2013.

Last executed offering

May 4, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Jul 13, 2026

S-3/A — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Aug 3, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 13, 2026	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jun 23, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 4, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 2, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 23, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 22, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 27, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 22, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 14, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 12, 2024	RW →	WITHDRAWN	Registration withdrawn
Jul 12, 2024	RW →	WITHDRAWN	Registration withdrawn
May 30, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 30, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 29, 2023	RW →	WITHDRAWN	Registration withdrawn
Nov 13, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 1, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 30, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 27, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 27, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 24, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Oct 13, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jul 24, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 27, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 15, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 3, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 4, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 28, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 26, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 19, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 17, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 14, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 14, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 21, 2018	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 14, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 6, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 22, 2018	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 21, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)

GYRE offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GYRE workspace →

GYRE offering FAQ

When did GYRE last execute an offering?

Per SEC filings, GYRE THERAPEUTICS, INC.'s most recent priced offering document is a 8-K filed 2026-05-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GYRE last announce or register an offering?

The most recent registration is a S-3/A filed 2026-07-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.